Simulated hyperglycemia impairs insulin signaling in endothelial cells through a hyperosmolar mechanism

Vascul Pharmacol. 2020 Jul:130:106678. doi: 10.1016/j.vph.2020.106678. Epub 2020 Mar 27.

Abstract

Background: Hyperglycemia plays a role in promoting insulin resistance in adipocytes, hepatocytes and myocytes. Its effects on insulin signaling in endothelial cells remain, however, incompletely understood.

Aim: To investigate the proteomic and metabolomic profiles of human aortic endothelial cells (HAECs) exposed to insulin, normal glucose (NG), high glucose (HG) or its hyperosmolar control high mannitol (HM), and to examine whether and how HG or HM may promote insulin resistance.

Methods and results: We exposed HAECs to HG and HM in shorter (3 h) and longer-term experiments (24 h), followed by insulin treatment for 45 min. Label-free proteomics and network analysis showed a downregulation of proteins linked to the PI3K-Akt/mTOR/eNOS signaling pathway in HAECs. Metabolomic profiling showed decreased levels of "odd-chain acylcarnitines" such as C3. At immunoblotting, HG or HM blunted insulin ability to activate the PI3K/AKT/eNOS pathway, which was reverted through a silencing of aquaporin 1 (AQP1) and Tonicity enhancer binding protein (TonEBP), while inducing p-P38 and pERK1/2.

Conclusions: HG impairs the PI3K/AKT/eNOS pathway and shifts insulin signaling towards the activation of mitogenic and pro-inflammatory effectors, such as p38 and ERK1/2. These effects may explain the progression of insulin resistance as a result of endothelial glucotoxicity.

Keywords: Diabetes; Endothelial cells; Hyperosmotic stress; Insulin resistance; Omics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aquaporin 1 / genetics
  • Aquaporin 1 / metabolism
  • Cells, Cultured
  • Endothelial Cells / drug effects*
  • Endothelial Cells / metabolism
  • Energy Metabolism / drug effects*
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Glucose / toxicity*
  • Humans
  • Hyperglycemia / genetics
  • Hyperglycemia / metabolism*
  • Hyperglycemia / physiopathology
  • Insulin / pharmacology*
  • Insulin Resistance*
  • Mannitol / pharmacology
  • Nitric Oxide Synthase Type III / metabolism
  • Osmolar Concentration
  • Osmotic Pressure / drug effects
  • Phosphatidylinositol 3-Kinase / metabolism
  • Phosphorylation
  • Protein Interaction Maps
  • Proto-Oncogene Proteins c-akt / metabolism
  • Signal Transduction
  • TOR Serine-Threonine Kinases / metabolism
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • AQP1 protein, human
  • Insulin
  • NFAT5 protein, human
  • Transcription Factors
  • Aquaporin 1
  • Mannitol
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III
  • MTOR protein, human
  • Phosphatidylinositol 3-Kinase
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases
  • Extracellular Signal-Regulated MAP Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Glucose